Eli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the disease.
Zacks via Yahoo
3 hours ago
Insider Monkey via Yahoo
Eli Lilly and Company (LLY): A Good Growth Stock To Buy Now According to Billionaire Ray Dalio
5 days ago
5 Top-Performing S&P 500 Stocks of 1H Set to Shine Further
2 days ago
Fortune via Yahoo
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
6 days ago
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
View all
American businessperson and philanthropist
Eli Broad was an American businessman and philanthropist. In June 2019, Forbes ranked him as the 233rd-wealthiest person in the world and the 78th-wealthiest in the United States, with an estimated net worth of $6.7 billion. Wikipedia